• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中的上皮-间充质转化。

Epithelial-mesenchymal transition in hepatocellular carcinoma.

机构信息

Department of Medicine I, Division: Institute of Cancer Research, Medical University of Vienna, Borschke-Gasse 8a, A-1090 Vienna, Austria.

出版信息

Future Oncol. 2009 Oct;5(8):1169-79. doi: 10.2217/fon.09.91.

DOI:10.2217/fon.09.91
PMID:19852728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2963061/
Abstract

The transition of epithelial cells to a mesenchymal phenotype is of paramount relevance for embryonic development and adult wound healing. During the past decade, the epithelial-mesenchymal transition (EMT) has been increasingly recognized to occur during the progression of various carcinomas such as hepatocellular carcinoma (HCC). Here, we focus on EMT in both experimental liver models and human HCC, emphasizing the underlying molecular mechanisms which show partial recurrence of embryonic programs such as TGF-beta and Wnt/ beta-catenin signaling, including collaboration with hepatitis viruses. We further discuss the differentiation repertoire of malignant hepatocytes with respect to the potential acquisition of stemness, and the involvement of the mesenchymal to epithelial transition, the reversal of EMT, in cancer dissemination and metastatic colonization. The strong evidence for EMT in HCC patients demands novel strategies in pathological assessments and therapeutic concepts to efficiently combat HCC progression.

摘要

上皮细胞向间充质表型的转变对于胚胎发育和成人伤口愈合至关重要。在过去的十年中,人们越来越认识到上皮-间充质转化(EMT)在各种癌症如肝细胞癌(HCC)的进展过程中发生。在这里,我们重点介绍 EMT 在实验性肝模型和人类 HCC 中的作用,强调了潜在的分子机制,这些机制显示出部分胚胎程序的重现,如 TGF-β和 Wnt/β-catenin 信号通路,包括与肝炎病毒的合作。我们进一步讨论了恶性肝细胞的分化谱,以及获得干性的潜在可能性,以及间质到上皮的转变、EMT 的逆转在癌症扩散和转移定植中的作用。EMT 在 HCC 患者中的有力证据要求在病理评估和治疗概念方面采取新的策略,以有效地对抗 HCC 的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/6d24c41bde7d/ukmss-32703-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/f352d019c206/ukmss-32703-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/e133005139b5/ukmss-32703-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/f3e0f51233eb/ukmss-32703-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/6d24c41bde7d/ukmss-32703-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/f352d019c206/ukmss-32703-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/e133005139b5/ukmss-32703-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/f3e0f51233eb/ukmss-32703-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c749/2963061/6d24c41bde7d/ukmss-32703-f0004.jpg

相似文献

1
Epithelial-mesenchymal transition in hepatocellular carcinoma.肝细胞癌中的上皮-间充质转化。
Future Oncol. 2009 Oct;5(8):1169-79. doi: 10.2217/fon.09.91.
2
Mechanisms of the epithelial-mesenchymal transition by TGF-beta.TGF-β诱导的上皮-间充质转化的机制。
Future Oncol. 2009 Oct;5(8):1145-68. doi: 10.2217/fon.09.90.
3
lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells.长链非编码 RNA HOTAIR 过表达诱导 c-Met 信号下调促进肝癌细胞的混合上皮/间充质表型。
Cell Commun Signal. 2020 Jul 11;18(1):110. doi: 10.1186/s12964-020-00602-0.
4
Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.血清反应因子在肝细胞癌中的表达:对上皮-间质转化的影响
Int J Oncol. 2007 Dec;31(6):1309-15.
5
Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.核 β-连环蛋白在肝细胞癌中诱导早期肝祖细胞表型,并促进肿瘤复发。
Am J Pathol. 2010 Jan;176(1):472-81. doi: 10.2353/ajpath.2010.090300. Epub 2009 Dec 11.
6
Epithelial-mesenchymal transition in development and cancer.上皮-间充质转化在发育和癌症中的作用。
Future Oncol. 2009 Oct;5(8):1129-43. doi: 10.2217/fon.09.94.
7
Epithelial-mesenchymal transition in the liver.肝脏中的上皮-间质转化
Gastroenterol Clin Biol. 2010 Oct;34(10):523-8. doi: 10.1016/j.gcb.2010.04.017. Epub 2010 Jul 7.
8
Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches.调控肝细胞癌上皮-间充质转化的机制和靶向治疗方法。
Adv Exp Med Biol. 2024;1450:93-102. doi: 10.1007/5584_2023_781.
9
Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.在肝干细胞恶性转化过程中,Tg737通过Snail和HNF4α之间的负反馈回路调节上皮-间质转化和癌症干细胞特性。
Cancer Lett. 2017 Aug 28;402:52-60. doi: 10.1016/j.canlet.2017.05.005. Epub 2017 May 20.
10
Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.转化生长因子-β诱导的可塑性导致肝细胞癌出现迁移性干性表型。
Cancer Lett. 2017 Apr 28;392:39-50. doi: 10.1016/j.canlet.2017.01.037. Epub 2017 Feb 2.

引用本文的文献

1
Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance.解析河马通路:YAP/TAZ在癌症转移和耐药性中扮演核心角色。
EXCLI J. 2025 Jun 6;24:612-637. doi: 10.17179/excli2025-8351. eCollection 2025.
2
Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.重新审视治疗策略:应对肝细胞癌中上皮-间质转化诱导的耐药性
BME Front. 2025 Jun 24;6:0144. doi: 10.34133/bmef.0144. eCollection 2025.
3
Knockdown of Plexin C1 induces epithelial-to-mesenchymal transition and confers resistance to multikinase inhibitors in hepatocellular carcinoma cells.敲低丛状蛋白C1可诱导肝癌细胞发生上皮-间质转化并赋予其对多激酶抑制剂的抗性。
Turk J Biol. 2025 Jan 8;49(2):219-232. doi: 10.55730/1300-0152.2739. eCollection 2025.
4
The role of FOXA1 and miR-212-3p in molecular modulation of doxorubicin resistance in liver cancer.FOXA1和miR-212-3p在肝癌多柔比星耐药分子调控中的作用
Med Oncol. 2025 Apr 11;42(5):160. doi: 10.1007/s12032-025-02686-5.
5
GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma.GULP1作为肝细胞癌一种新型的诊断和预测生物标志物
Clin Mol Hepatol. 2025 Feb 6. doi: 10.3350/cmh.2024.1038.
6
TUBB2B regulates epithelial-mesenchymal transition via interaction with Vimentin to promote glioma migration and invasion.TUBB2B通过与波形蛋白相互作用调节上皮-间质转化,以促进胶质瘤的迁移和侵袭。
Cancer Cell Int. 2024 Dec 20;24(1):423. doi: 10.1186/s12935-024-03618-5.
7
Comparative transcriptomic analysis uncovers molecular heterogeneity in hepatobiliary cancers.比较转录组分析揭示了肝胆癌中的分子异质性。
Transl Oncol. 2025 Jan;51:102192. doi: 10.1016/j.tranon.2024.102192. Epub 2024 Nov 14.
8
A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease.一个预测的上皮间质转化相关的 mRNA/miRNA 轴有助于糖尿病肝疾病的进展。
Sci Rep. 2024 Nov 12;14(1):27678. doi: 10.1038/s41598-024-77416-4.
9
Emerging Prognostic Markers in Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Narrative Review.肝细胞癌肝切除患者新出现的预后标志物:一项叙述性综述。
Cancers (Basel). 2024 Jun 10;16(12):2183. doi: 10.3390/cancers16122183.
10
Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications.了解连接蛋白在肝细胞癌中的作用:分子及预后意义
Cancers (Basel). 2024 Apr 17;16(8):1533. doi: 10.3390/cancers16081533.

本文引用的文献

1
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.微小RNA-122,一种调节肝细胞癌肝内转移的抑癌微小RNA。
Hepatology. 2009 May;49(5):1571-82. doi: 10.1002/hep.22806.
2
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.细胞外基质调节肝细胞对成纤维样去分化和转化生长因子β诱导的细胞凋亡的敏感性。
Hepatology. 2009 Jun;49(6):2031-43. doi: 10.1002/hep.22880.
3
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.上皮细胞与间充质细胞状态之间的转变:恶性特征和干细胞特征的获得。
Nat Rev Cancer. 2009 Apr;9(4):265-73. doi: 10.1038/nrc2620. Epub 2009 Mar 5.
4
Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition.肝癌衍生的丙型肝炎病毒核心蛋白将转化生长因子-β反应从肿瘤抑制转变为上皮-间质转化。
PLoS One. 2009;4(2):e4355. doi: 10.1371/journal.pone.0004355. Epub 2009 Feb 3.
5
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.靶向转化生长因子(TGF)-βRI可抑制β1整合素的激活并阻断肝细胞癌的血管侵袭。
Hepatology. 2009 Mar;49(3):839-50. doi: 10.1002/hep.22731.
6
ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.ILEI在肝细胞上皮-间质转化和肝癌进展过程中需要致癌性Ras。
Oncogene. 2009 Feb 5;28(5):638-50. doi: 10.1038/onc.2008.418. Epub 2008 Nov 17.
7
Mechanisms of disease progression in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的疾病进展机制
Semin Liver Dis. 2008 Nov;28(4):370-9. doi: 10.1055/s-0028-1091981. Epub 2008 Oct 27.
8
Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron.肝脏疾病中的辅助因子:HFE相关遗传性血色素沉着症与铁的作用
Biochim Biophys Acta. 2009 Jul;1790(7):663-70. doi: 10.1016/j.bbagen.2008.09.002. Epub 2008 Sep 20.
9
Symptom management in hepatocellular carcinoma.肝细胞癌的症状管理
Clin J Oncol Nurs. 2008 Oct;12(5):759-66. doi: 10.1188/08.CJON.759-766.
10
Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.肝细胞癌中E-钙黏蛋白/连环蛋白复合体表达降低。
World J Gastroenterol. 2008 Oct 7;14(37):5665-73. doi: 10.3748/wjg.14.5665.